SCHEMBL1287602

SCHEMBL1287602

CC(C)(C)OC(=O)c1ccc(CN(C2COC(C)(C)OC2)S(=O)(=O)c2ccc(Cl)s2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 3/20 0.36
PSEN2 P49810 3/20 0.36
APH1B Q8WW43 3/20 0.36
NCSTN Q92542 3/20 0.36
APH1A Q96BI3 3/20 0.36
PSENEN Q9NZ42 3/20 0.36
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
HDAC6 Q9UBN7 6/20 0.33
HDAC8 Q9BY41 4/20 0.33
HDAC11 Q96DB2 2/20 0.33
NR1D1 P20393 1/20 0.32
GPR119 Q8TDV5 2/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32
KDM1A O60341 2/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287307 0.90 RAB9A (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1287498 0.87 MEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10206745 0.74 PSEN1 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1287427 0.74 MAPT (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1287372 0.65 RAB9A (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1287984 0.63 RAB9A (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL19120562 0.62 GPR119 (0.49) SIRT2SIRT1HDAC6GPR119CA12
SCHEMBL1287277 0.60 ALDH1A1 (0.59) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6592668 0.60 CA12 (0.51) SIRT2SIRT1HDAC6GPR119CA12
SCHEMBL3126755 0.60 CA1 (0.48) SIRT2SIRT1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130310384-A1 Sulfonamide-Containing Compounds THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2013-11-21 US disclosed
WO-2012047926-A2 SULFONAMIDE-CONTAINING COMPOUNDS THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130310384-A1 Sulfonamide-Containing Compounds BACE1, BACE2, GSAP PSEN1 4/4885PSEN2 5/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.